Clinical Trials on Early Assessment of AKI After TAAA Repair in Finland
Total 0 results
Nothing found
Sponsors and Collaborators
- Prostate Cure Foundation
- Rotem Petranker
- Ondine Biomedical Inc.
- Robert Pendleton
- Stanford's Innovative Medicines Accelerator
- Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital
- Daqiao Community Health Service Center of Yangpu District
- University Mental Health Research Institute, Athens, Greece
- Michael Scharl
- National Institute of Drug Abuse
- Julie Lefevere
- AVAX Technologies
- Ancon Technologies Ltd
- Montera Health Texas LLC
- Azumio Inc.
- Manresana de Micobacteriologia, SL
- Genesis Foundation
- National Institute of Diabetes and Endocrinology, Egypt
- Spokane Regional Health District
- Health Factors Inc
- View Full List
Medical Conditions
- Skin Burn Multiple
- Age of Probands 18 - 55 Years
- Vital Signs
- Universal Adhesive
- Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma
- Isolation of Enterococci From Samples
- Glanzmann's Thrombasthenia
- Unwanted Abdomen Fat
- Connective Active Program
- Pain Due to Childhood Vaccination
- Simulation Training, Laparoscopy
- Immunochromatographic
- Thymoglobulin Dose
- Acute Myocardial Infarction With ST Segment Elevation
- Desmoid
- Limb-Girdle Muscular Dystrophy, Type 2I (FKRP-deficiency)
- Convalescent Plasma for COVID 19
- Ischemic Stroke, Cryptogenic
- Peripheral Artery Calcification
- Conditions for Which There is a Documented Medical Necessity to Receive Treatment With Rotigotine
- View Full List
Drug Interventions
- GSK3145095
- Pembrolizumab, pemetrexed, platinum
- Acitretin
- Vatiquinone
- Genicular nerve block with lidocaine
- Avatrombopag (higher baseline platelet count)
- 0.9% sodium chloride
- Morphine ,ketorolac
- Cilengitide
- HH-003 and NrtIs
- Azithromycin 1 gram IV
- Oxaliplatin and 5-fluorouracil
- Lotrel® Capsules 10 mg/20 mg
- Buprenorphine transdermal patch
- Tremelimumab
- Oxaliplatin
- Clonidine 1 mcg/Kg
- Pemetrexed
- Human chorionic gonadotropin (hCG), then epoetin alfa (EPO)
- CDA Inhibitor E7727/Decitabine Combination Agent ASTX727
- View Full List
CROs by country
- Contract Research Organizations in Austria
- Contract Research Organizations in Belarus
- Contract Research Organizations in Cote d'Ivoire
- Contract Research Organizations in Cyprus
- Contract Research Organizations in Guatemala
- Contract Research Organizations in Italy
- Contract Research Organizations in Kuwait
- Contract Research Organizations in Mexico
- Contract Research Organizations in Montenegro
- Contract Research Organizations in Oman
- Contract Research Organizations in Qatar
- Contract Research Organizations in Türkiye
- Contract Research Organizations in Zambia
- CRO list by country